Temperature control
All peptide pen orders are securely packed in thermally insulated packaging to help reduce temperature fluctuations during transport. Our MSSPT formulation approach is designed to support peptide stability during transport and storage. After delivery, follow the storage conditions stated for your pen.
MSSPT technology
MSSPT is ADRIA’s formulation approach for liquid peptide research materials. It brings together buffer and stabilizer selection with attention to light, oxidation, transport and storage conditions.
Performance depends on the specific compound, formulation and cartridge. Product-specific stability duration is not established by general ingredient studies.
Peptide Pens
CJC-1295 (no-DAC) + Ipamorelin Pen
In stock
Order within — to ship today
Arrives 26 – 30 Nov. to Europe
CJC-1295 (no-DAC) + Ipamorelin Pen
Original price was: 270,00 €.229,50 €Current price is: 229,50 €.
The ADRIA CJC-1295 (no-DAC) + Ipamorelin Pen presents CJC-1295 (no-DAC) + Ipamorelin in a pre-reconstituted cartridge format for laboratory research. CJC 1295(no dac) + Ipamorelin is Synergistic GHRH and GHRP Blend for GH Release and Recovery Research
Compound information
Specifications
Molecular profile
- Sequence
- CJC-1295 no-DAC: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2; Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Molecular mass
- CJC-1295 no-DAC: 3367.9 g/mol; Ipamorelin: 711.9 g/mol.
- CAS number
- CJC-1295 no-DAC: 446036-97-1; Ipamorelin: 170851-70-4.
- Molecular formula
- CJC-1295 no-DAC: C152H252N44O42; Ipamorelin: C38H49N9O5.
Material record
- Physical appearance
- Pre-mixed solution in a cartridge (planned pen format).
- Solubility
- Pre-reconstituted format; no reconstitution required.
- Product note
- Two-component peptide blend; studied around GHRH and ghrelin receptor pathway models; supplied strictly for research use only.
Research overview
CJC-1295 (no-DAC) + Ipamorelin Pen
Why this pen is perfect for research
- No preparation required
- Fully pre-formulated and ready. No mixing, no vials, no risk of mistakes.
- Extremely easy to handle
- Simply turn the dial to set your amount. Ideal for researchers with no prior experience using traditional peptides.
- Clean and safe workflow
- The closed pen system keeps everything hygienic and sterile and eliminates spills or contamination.
- Precise and consistent dosing
- The built-in scale ensures accurate measurements
- Reliable, stable quality
- Every application delivers the same concentration, supporting reproducible research results.
What is CJC 1295 with Ipamorelin?
CJC 1295 with Ipamorelin is a dual action peptide blend combining two research backed growth hormone stimulators.
CJC 1295 is a GHRH analog that promotes natural GH release via GHRH receptors.
Ipamorelin is a highly selective GHRP peptide that triggers ghrelin receptors to amplify GH pulses without affecting cortisol or prolactin in research models.
This blend delivers a balanced and synergistic effect for studies exploring GH secretion, recovery pathways and metabolic performance.
Ideal for research in regenerative biology, performance recovery and endocrine signaling.
Key Research Findings
- Dual Mechanism GH Release: CJC activates GHRH pathways, Ipamorelin activates ghrelin receptors.
- Balanced Synergy: 5 mg CJC and 5 mg Ipamorelin support stable GH pulses and predictable pharmacodynamics.
- Recovery and Repair: Shown in research to enhance tissue regeneration and protein synthesis.
- Lean Mass Support: Investigated for its role in maintaining lean tissue and improving metabolic output.
- Highly Selective Profile: Ipamorelin offers targeted GH release with minimal off target hormonal effects.
Why Choose CJC 1295 with Ipamorelin?
- The 5 mg plus 5 mg ratio of this blend provides a precise and effective combination of GHRH and GHRP activity.
- Its coordinated dual mechanism, strong research background and reliable GH pulse profile make it one of the most commonly used blends in recovery, metabolic and regenerative studies.
Explore the potential of CJC 1295 with Ipamorelin 10 mg for advanced GH and tissue repair research.
For laboratory purposes and personal observation only. Not for human consumption.
Research material handling
Transport and storage
Pre-mixed pen format
Peptide pens are supplied as a pre-mixed solution in a cartridge. No reconstitution is required.
Temperature-controlled transport
The supplied handling specification calls for insulated, temperature-controlled packaging. The approved transit range and permitted temperature excursions must be confirmed for the finished formulation.
Storage of reconstituted peptides
Peptide pens come pre-reconstituted and should be stored under refrigerated conditions whenever possible.
The following storage conditions are generally recommended:
- Room temperature (15–25 °C): Avoid prolonged storage
- Refrigerated (2–8 °C): Typically 4–8 weeks
Important: Most manufacturers recommend discarding reconstituted peptides within 4 weeks when stored at 2–8 °C. This recommendation is intentionally conservative and may not reflect the actual chemical stability of every peptide. In our own stability studies, many peptides reconstituted in bacteriostatic water showed no detectable degradation after 12 weeks of refrigerated storage. As peptide stability is highly sequence- and formulation-dependent, this result should not be extrapolated to all peptides without supporting stability data.
Analytical documentation
Tests
Latest published result
Liquilabs s.r.o.Signed Certificate of Analysis · 10 mg + 10 mg
See reportPurity by HPLC
Recorded QC panel
- Ipamorelin AssayPeptide screening
- 11.47 mg
- MOD GRF (1-29) AssayPeptide screening
- 10.57 mg
- Ipamorelin PurityPeptide screening
- 99.7%
- MOD GRF (1-29) PurityPeptide screening
- 99.6%
- Ipamorelin Identity (FTIR)FTIR spectrum
- 996
- MOD GRF (1-29) Identity (FTIR)FTIR spectrum
- 994
- Ipamorelin Identity (RT)Retention time
- 0.992
- Bacterial EndotoxinUSP / Eur. Ph. 2.6.14
- 0.009 EU/mg
- Molecular Ion MassMS deconvolution
- 711 Da
- Molecular Ion MassMS deconvolution
- 3367 Da
These are the latest published results for this strength. The batch number is printed on each vial. Your supplied batch is confirmed against the matching published record when your order is allocated.
Source record
References
National Center for Biotechnology Information
PubChem Compound Summary: CJC-1295
Identity record for the CJC-1295 component.
PubChem View source ↗National Center for Biotechnology Information
PubChem Compound Summary: Ipamorelin
Identity record for the Ipamorelin component.
PubChem View source ↗Teichman SL, Neale A, Lawrence B, et al. · 2006
Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of growth hormone-releasing hormone, in healthy adults
Context for long-acting DAC CJC-1295 only; this paper does not establish which CJC form is present in the sold blend.
Journal of Clinical Endocrinology and Metabolism · 10.1210/jc.2005-1536 View source ↗Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA · 2006
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
The Journal of clinical endocrinology and metabolism View source ↗Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH · 1998
Ipamorelin, the first selective growth hormone secretagogue
European journal of endocrinology View source ↗Shrestha P, Sabharwal G, Ghaffari G · 2018
A Novel STAT3 Gene Mutation Related Hyper-IgE Syndrome Misdiagnosed as Hidradenitis Suppurativa
Case reports in immunology View source ↗Sander HJ, Kramer P, van Leeuwen EC, van Cappellen WA, Meijs-Roelofs HM, De Jong FH · 1991
Ovulation rate, follicle population and FSH levels in cyclic rats after administration of an inhibin-neutralizing antiserum
The Journal of endocrinology View source ↗Kallio P, Murphy ED · 1998
Soluble CD27 in thyroid disorders
The Journal of laboratory and clinical medicine View source ↗Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, Dousset B, Bertagna X, Bertherat J · 2006
Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients
The Journal of clinical endocrinology and metabolism View source ↗Customer reviews
Quality products,fast shipping,great refferal plan,only downside is that products in 4 mounths since my first order got more and more expensive ,but overall verry good experience.
Read full review →More than 2 weeks for package dispatch. They promised one free peptide next time. Sent me new tracking number but package still wasn't delivered to fedex. Last package (much much cheaper) was delivered in less than week. I will update if they will send my package. ok,package sent.
Read full review →Extremely satisfied with the product quality and overall experience. The customer service is polite and quick. All recommendations!
Read full review →Great service!
Read full review →Always on time and customer care is super great
Read full review →Fast good, and quality is perfect
Read full review →ordered 3 times now and everything ok every time.
Read full review →Trustworthy site with a huge catalog of products. Been purchasing from them for some time now never got disappointed. I could only recommend them.
Read full review →Great quality product
Read full review →Everything was great, super customer support, honest, reliable
Read full review →Everything ok. With little problem with package, but after contact with Customer Service everything went right. Good quality of products
Read full review →Excellent. Buying peptides online can be nerve wracking! But Adria are very transparent about all the checks and certifications. My experience with them was excellent. Great products at good prices and efficient P&P
Read full review →



